2020
DOI: 10.1371/journal.pone.0230870
|View full text |Cite
|
Sign up to set email alerts
|

Herpes simplex virus 1 regulates β-catenin expression in TG neurons during the latency-reactivation cycle

Abstract: When herpes simplex virus 1 (HSV-1) infection is initiated in the ocular, nasal, or oral cavity, sensory neurons within trigeminal ganglia (TG) become infected. Following a burst of viral transcription in TG neurons, lytic cycle viral genes are suppressed and latency is established. The latency-associated transcript (LAT) is the only viral gene abundantly expressed during latency, and LAT expression is important for the latency-reactivation cycle. Reactivation from latency is required for virus transmission an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 56 publications
0
8
0
Order By: Relevance
“…The Wnt/␤-catenin pathway is induced during BoHV-1 latency but repressed during DEX-induced reactivation (25,31,32). Mice latently infected with wild-type HSV-1 contain significantly more TG neurons that express ␤-catenin than those in an LAT-null mutant (33). Akt family members and the Wnt signaling pathway form a positive regulatory loop (34)(35)(36)(37)(38)(39), suggesting that these signaling pathways promote the maintenance of latency.…”
mentioning
confidence: 99%
“…The Wnt/␤-catenin pathway is induced during BoHV-1 latency but repressed during DEX-induced reactivation (25,31,32). Mice latently infected with wild-type HSV-1 contain significantly more TG neurons that express ␤-catenin than those in an LAT-null mutant (33). Akt family members and the Wnt signaling pathway form a positive regulatory loop (34)(35)(36)(37)(38)(39), suggesting that these signaling pathways promote the maintenance of latency.…”
mentioning
confidence: 99%
“…In contrast, abortive reactivations are often lethal ( Doll et al, 2020 ). It is as yet also unclear whether transcriptional silencing is a direct result of the specific anatomy of the neurons, active shut down by viral factors, differential gene expression, signaling, protein localization, neuronal type, the terminally differentiated state of the neurons, or a variety of other factors ( Cabrera et al, 2018 ; Chen et al, 1997 ; Flowerdew et al, 2013 ; Hafezi et al, 2012 ; Harrison et al, 2020 ; Kobayashi et al, 2012b ; Kristie et al, 1999 ; Margolis et al, 2007 ; Maroui et al, 2016 ; Nicoll et al, 2016 ; Zhao et al, 2020 ). In summary, silencing at the establishment of latency is still the least understood stage in latency.…”
Section: The Hsv-1 Epigenomementioning
confidence: 99%
“… Reduces latency reactivation by approximately threefold [ 29 ] HSV-1 17Syn+ 17ΔPst Deletion of the 118664–118886 core promoter of LAT Reduces latency reactivation by approximately 3-fold [ 49 ] HSV-1 McKrae dLAT2903 LAT nucleotides (−)161 to +1667 Increased neurovirulence, and slightly more rapid reactivation [ 56 ] HSV-1 McKrae dLAT2903R Deletion of LAT1 (−161 to 1667) relative to the start of the primary 8.3-kb LAT Reactivate from latency is significantly reduced. [ 83 ] HSV-1 17syn+ LATRz-235 Deletions in the LAT promoter and portions of the 5ʹ exon coding region Resulting in a two- to threefold decreased reactivation [ 84 ] …”
Section: Application Of Hsv Lat Deletion Mutants In Hsv Vaccines and Ohsvsmentioning
confidence: 99%
“… 81 Other studies have shown that deletion of LAT can significantly reduce HSV reactivation. 31 , 82 , 83 In addition, studies have also shown that deletion of LAT can significantly reduce reactivation to about 33% of the normal level. 3 Similarly, partial LAT deletion mutation has been shown to lead to an approximately threefold increase of latency in the TG of wild-type mice infected with LAT(+) virus compared with mice infected with LAT(-) virus.…”
Section: Application Of Hsv Lat Deletion Mutants In Hsv Vaccines and Ohsvsmentioning
confidence: 99%